The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Meeting the War Department’s Edge Computing Challenge
Matt Barry discusses how HP Federal is supporting mission-critical environments with secure, resilient and interoperable edge technologies.
7m watch -
Inside the Navy’s Push for Trustworthy AI at the Tactical Edge
From new tools to new education pipelines, the service is building a disciplined framework for AI in operations.
12m watch -
Feds Confront AI Skills Gap Amid Rapid Adoption Push
As AI use cases double across government, officials said workforce understanding and trust remain key barriers to implementation.
2m read -
How Government is Using AI as a Workforce Assistant
Agencies are increasingly deploying AI assistants to support criminal investigations, software development and cybersecurity monitoring.
3m read
